Antagonist of M1 muscarinic acetylcholine receptor prevents neurotoxicity induced by amphetamine via nitric oxide pathway

Annals of the New York Academy of Sciences

Volumn 1139, Issue , 2008, Pages 172-176

  Bashkatova, Valentina ^a   Hornick, Ariane ^b   Vanin, Anatoly ^c   Prast, Helmut ^b  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

Author keywords

Amphetamine; Lipid peroxidation; M1 muscarinic acetylcholine receptor; Neurotoxicity; Nitric oxide

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC TOXIN 7; NITRIC OXIDE; UNCLASSIFIED DRUG; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; LIPID PEROXIDATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION;

EID: 53549105839     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1432.004     Document Type: Conference Paper

References (21)

1. West, A., M. Galloway & A. Grace. 2002. Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 44 : 227 245.
2. Prast, H. & A. Philippu. 2001. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64 : 51 68.
3. Bashkatova, V., M. Kraus, A. Vanin, et al. 2004. Comparative effects of NO synthase inhibitor and NMDA antagonist on generation of nitric oxide and release of amino acids and acetylcholine in the rat brain elicited by amphetamine neurotoxicity. Ann. N. Y. Acad. Sci. 1025 : 221 230.
4. Clader, J. & Y. Wang. 2005. Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease. Curr. Pharm. Des. 11 : 3353 3361.
5. Caccamo, A., S. Oddo, L. Billings, et al. 2006. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49 : 671 682.
6. Joseph, J., B. Shukitt-Hale, G. Casadesus & D. Fisher. 2005. Oxidative stress and inflammation in brain aging: nutritional considerations. Neurochem. Res. 30 : 927 935.
7. Kawaguchi, Y., C.J. Wilson, S.J. Auwood & P.C. Emson. 1995. Striatal interneurons: chemical, psychiological and morphological characterization. Trends Neurosci. 18 : 527 535.
8. Harrington, A.M., J.M. Hutson & B.R Southwell. 2007. Immunohistochemical localisation of cholinergic muscarinic receptor subtype 1 (M1r) in the guinea pig and human enteric nervous system. J. Chem. Neuroanat. 33 : 193 201.
9. Itzhak, Y. & SF Ali. 2006. Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs. Pharmacol. Ther. 109 : 246 262.
10. Prast, H., H. Fischer, E. Werner, et al. 1995. Nitric oxide modulates the release of acetylcholine in the ventral striatum of the freely moving rat. Naunyn-Schmiedebergs Arch. Pharmacol. 352 : 67 73.
11. Buchholzer, M.L. & J. Klein. 2002. NMDA-induced acetylcholine release in mouse striatum: role of NO synthase isoforms. J. Neurochem. 82 : 1558 1560.
12. Mikoyan, V.D., N.V. Voevodskaya, L.N. Kubrina, et al. 1995. The influence of antioxidants and cycloheximide on the level of nitric oxide in the livers of mice in vivo. Biochim. Biophys. Acta 1269 : 19 24.
13. Ohkawa, H., N. Ohishi & K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 : 351 358.
14. Sterin-Borda, L., S. Ganzinelli, A. Berra & E. Borda. 2003. Novel insight into the mechanisms involved in the regulation of the m1 muscarinic receptor, iNOS and nNOS mRNA levels. Neuropharmacology 45 : 260 269.
15. Ganzinelli, S., T. Borda & L. Sterin-Borda. 2006. Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients. Neuropharmacology 50 : 362 371.
16. Mangelus, M., A. Kroyter, R. Galron & M. Sokolovsky. 2001. Reactive oxygen species regulate signaling pathways induced by M1 muscarinic receptors in PC12M1 cells. J. Neurochem. 76 : 1701 1711.
17. Picconi, B., I. Barone, A. Pisani, et al. 2006. Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine. Neuropharmacology 50 : 917 923.
18. Farías, G., J.A. Godoy, F. Hernández, et al. 2004. M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity: a role for Wnt signaling pathway. Neurobiol. Dis. 17 : 337 348.
19. Kang, T.H., Y. Murakami, H. Takayama, et al. 2004. Protective effect of rhynchophylline and isorhynchophylline on in vitro ischemia-induced neuronal damage in the hippocampus: putative neurotransmitter receptors involved in their action. Life Sci. 76 : 331 343.
20. Wirtshafter, D. 2006. The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression. Brain Res. 1085 : 127 131.
21. Izurieta-Sánchez, P., S. Sarre, G. Ebinger & Y. Michotte. 2000. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum. Eur. J. Pharmacol. 399 : 151 160.